The potential prognostic value of mTOR and phosphorylated mTOR (p-mTOR) has also been extensively studied in a variety of cancers, including lung cancer [18], gastric cancer [19, 20], breast cancer [21], colorectal cancer [22, 23] and urological cancer [24]. Here, MTOR is linked to lung cancer.